Arcutis Biotherapeutics Inc. Share Price Today, Forecast Target, Chat & Where To Buy [ARQT]

Home > Share Prices > Arcutis Biotherapeutics Inc. share price (ARQT)

Today's Arcutis Biotherapeutics Inc. share price is 31.2 (as of 16:00 05-Dec-2025) which is a change of 0.04 or 0.13% from the last closing price of 31.2 with 1,284,747 shares traded giving Arcutis Biotherapeutics Inc. a market capitalisation of 3,821,756,733. The most recent daily high has been 31.45 and daily low 30.39. The Arcutis Biotherapeutics Inc. share price 52 week high has been 31.45 and the 52 week low 11.13. Based on the most recent Arcutis Biotherapeutics Inc. share price opening of 31.2, the current Arcutis Biotherapeutics Inc. EPS (earnings per share) are 0.35 and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying Arcutis Biotherapeutics Inc. Shares

It currently costs 31.2 to buy one share in Arcutis Biotherapeutics Inc. (as of 16:00 05-Dec-2025) which is a change of 0.04 or 0.13% from the last closing price of 31.16. To buy shares in Arcutis Biotherapeutics Inc. you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is Arcutis Biotherapeutics Inc. A Good Investment?

The below Arcutis Biotherapeutics Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top